Navigation Links
Enhanced Equity Fund and James White Invest in MedTest DX, Inc.
Date:5/19/2011

NEW YORK, May 19, 2011 /PRNewswire/ -- Enhanced Equity Fund (EEF), a healthcare-focused private equity firm, and executive James White announced their investment in MedTest DX, Inc. (MedTest), a medical diagnostic company based in Cortlandt Manor, NY.  MedTest was created to purchase the chemistry diagnostics business from Polymedco, Inc.  The transaction was led by Mark Tricolli, a Partner of EEF.  Terms were not disclosed.

"EEF is committed to building a leading platform in the medical diagnostics industry and our investment in MedTest represents an attractive initial asset from which to grow both organically and through acquisitions," said Mr. Tricolli.  He added, "We are excited to partner with James White, who has a proven track record in this industry, and provide capital for future growth initiatives."

James White, Chief Executive Officer of MedTest said, "EEF's investment in our chemistry assets represents a tremendous opportunity for MedTest to build on the company's strong reputation with its customers and suppliers in the marketplace.  Both EEF and MedTest share the same philosophy of delivering superior products and service and we are truly excited to join forces to capitalize on numerous growth opportunities."

About MedTest DX

MedTest was founded in 2011 and is based in Cortlandt Manor, NY.  The company sells a range of chemistry instruments, reagents, and instrument service to physician offices, hospitals, reference laboratories, and research facilities, both direct and through distribution channels in the U.S.  MedTest DX products include SPOTCHEM EZ, a compact benchtop dry chemistry analyzer that can run single and panel diagnostic tests with results available in 8-15 minutes.  In addition, the Poly-Chem 90 and 180 chemistry analyzers offer countertop instruments to run chemistry tests, including an integrated electrolyte module, data management and over 70 FDA cleared reagents.  Additional information about MedTest is available on the Company's website www.medtestdx.com.

About Enhanced Equity Fund

Based in New York, NY and founded in 2005 by Andrew M. Paul, EEF is a private equity fund with over $600 million of assets under management focused on providing capital to lower-middle market growth companies in the healthcare services industry. The firm's investment philosophy and strategy is to invest in smaller high growth companies and partner with successful entrepreneurs and management teams to build value through internal growth and acquisitions.  EEF is currently investing its newly-raised, over-subscribed, second fund.

For further information please contact:
Enhanced Equity Fund--Mark Tricolli (212) 207-3386
MedTest DX, Inc.--James White (914) 930.3111


'/>"/>
SOURCE MedTest DX, Inc.; Enhanced Equity Fund
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Improved Cornea Surgery Technique Provides Enhanced Transplant Success
2. CorMatrix(R) Announces Intramyocardial Injection of Emulsified ECM Technology(TM) Demonstrates Enhanced Angiogenesis and Improved Cardiac Function in a Preclinical Model
3. Biomoda to Present Paper on Enhanced Technology for Early Detection of Lung Cancer at Annual SWARM Meeting
4. Fuisz Tobacco Announces Clinical Study Results for Fuisz Tobacco Sheet Strip; Super Enhanced Bioavailability of Nicotine From Its Tobacco Sheet Strip Supports Efficacy of Low Dose Tobacco Product
5. Interleukin Genetics Launches Enhanced Heart Health Genetic Test Report Format
6. Perceptive Informatics Improves Clinical Trial Management With Enhanced TrialWorks(R) Solution
7. Data Reported at ICAAC Indicates Selzentry(TM) Phase III Treatment-Naive Trial Shows Increased Efficacy When Used With Enhanced Trofile(TM) Assay
8. Medarex Announces Enhanced Activity Data with Second Generation Anti-CD30 Antibody for Malignant Lymphoma
9. Enhanced Food Safety and Systems Interoperability the Themes of Food Traceability Interoperability Summit 2010
10. Riverain Medical Partners With The Christie Group In Canada To Offer SoftView Enhanced Chest Imaging and OnGuard Chest X-Ray CAD Technologies
11. Rauland-Borg and Visonic Technologies Collaboration Brings Enhanced RTLS Functionality to the Responder 5(R) Nurse Call System
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/19/2017)... YORK , April 19, 2017 Global ... drainage devices are tubes used to remove excess liquid ... blood, serum, pus, urine, bile or lymph. Surgical drains ... of surgery such as orthopedics surgery, cardiovascular surgery, neurosurgery, ... is prophylactic post-surgery to prevent accumulation of fluid e.g. ...
(Date:4/19/2017)... , April 19, 2017 The ... Application, Forecast to 2022 report has covered and analysed the ... and information on market size, shares and growth factors. The ... drivers, challenges and opportunities in the global market. ... Browse 152 Tables and Figures, 6 ...
(Date:4/19/2017)... 2017  New research provides evidence that an old drug ... a study released today that will be presented at the ... Boston , April 22 to 28, 2017. ... Parkinson,s disease, the oral drug levodopa has long been considered ... as the disease progresses, the effects of the medication can ...
Breaking Medicine Technology:
(Date:4/22/2017)... ... April 22, 2017 , ... ... PROSHRED® Security of Philadelphia its “Woman-Owned Small Business of the Year, ... providing information destruction , recycling, and compliance services to businesses throughout ...
(Date:4/21/2017)... ... 2017 , ... Providing broad access to life-saving drugs and rewarding the innovators ... way to address this problem. , That was the message from Dana Goldman, PhD, ... the University of Southern California, who served as the keynote speaker for Western University ...
(Date:4/21/2017)... Wis. (PRWEB) , ... April 21, 2017 , ... ... today announced that its B-595 and B-7569 vinyl label materials ... identification and warning labels are tested to remain intact and legible, for use on ...
(Date:4/21/2017)... Maine (PRWEB) , ... April 21, 2017 , ... ... today announced it’s been named Agency of Record (AOR) for Theravent, Inc. ... or eliminate snoring. Theravent’s parent company, Foundation Consumer Healthcare, is now working to ...
(Date:4/21/2017)... ... April 21, 2017 , ... ... an exciting new partnership with the highly regarded and well renowned Asian distributor, ... innovative, myTAP & myTAP PAP Nasal Pillow Mask, and will stabilize and strengthen ...
Breaking Medicine News(10 mins):